Skip to main content

and
  1. Article

    Open Access

    Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response

    We report the results of a prospective study on the immunogenicity of a 3rd dose of BNT162b2 in thoracic organ recipients with no or minimal response following a two-dose BNT162b2 vaccination scheme.

    Angelika Costard-Jäckle, René Schramm, Bastian Fischer in Clinical Research in Cardiology (2023)

  2. Article

    Open Access

    Akzeptanz einer telemetrischen Versorgung bei Patienten mit sICD-Sicherheitshinweis

    Telemonitoring dient der Überwachung von implantierbaren Kardioverter-Defibrillatoren (ICD). Trotz der wissenschaftlich nachgewiesenen Effektivität und Sicherheit der telemetrischen Versorgung zeigen Studien, ...

    Leonie König, Elisabeth Grünberg in Herzschrittmachertherapie + Elektrophysiol… (2023)

  3. Article

    Open Access

    Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation

    Rasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm in Clinical Research in Cardiology (2022)

  4. Article

    Open Access

    Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation

    Cardiac graft denervation causes inadequate sinus tachycardia in patients after heart transplantation (HTX) which is associated with reduced survival. This study investigated the 5-year results of heart rate c...

    Rasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm in Clinical Research in Cardiology (2022)

  5. Article

    Open Access

    Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients

    Immunocompromised patients have been excluded from studies of SARS-CoV-2 messenger RNA vaccines. The immune response to vaccines against other infectious agents has been shown to be blunted in such patients. W...

    René Schramm, Angelika Costard-Jäckle, Rasmus Rivinius in Clinical Research in Cardiology (2021)

  6. No Access

    Article

    Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes

    Atrial fibrillation (AF) is associated with electrical remodeling, leading to cellular electrophysiological dysfunction and arrhythmia perpetuation. Emerging evidence suggests a key role for epigenetic mechani...

    Patrick Lugenbiel, Katharina Govorov, Pascal Syren in Basic Research in Cardiology (2021)

  7. Article

    Open Access

    COVID-19 among heart transplant recipients in Germany: a multicenter survey

    Heart transplantation may represent a particular risk factor for severe coronavirus infectious disease 2019 (COVID-19) due to chronic immunosuppression and frequent comorbidities. We conducted a nation-wide su...

    Rasmus Rivinius, Ziya Kaya, René Schramm, Udo Boeken in Clinical Research in Cardiology (2020)

  8. No Access

    Article

    Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart

    Patients after heart transplantation (HTX) present with sinus tachycardia due to graft denervation. As elevated heart rates negatively affect survival, the aim of this study was to analyze the effects of ivabr...

    Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar in Clinical Research in Cardiology (2018)

  9. Article

    Open Access

    Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells

    Human induced pluripotent stem cells (hiPSC) harbor the potential to differentiate into diverse cardiac cell types. Previous experimental efforts were primarily directed at the generation of hiPSC-derived cell...

    Patrick A. Schweizer, Fabrice F. Darche, Nina D. Ullrich in Stem Cell Research & Therapy (2017)

  10. Article

    Open Access

    Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams

    High-energy ion beams are successfully used in cancer therapy and precisely deliver high doses of ionizing radiation to small deep-seated target volumes. A similar noninvasive treatment modality for cardiac ar...

    H. Immo Lehmann, Christian Graeff, Palma Simoniello in Scientific Reports (2016)